CA Patent

CA3032123A1 — Automated drug delivery systems and methods

Assigned to Alcyone Therapeutics Inc · Expires 2018-02-01 · 8y expired

What this patent protects

Automated drug delivery systems and related methods are disclosed herein. In some embodiments, these systems can reduce or eliminate infusion inconsistencies. An exemplary system can include a syringe actuator which can be controlled via electrical, mechanical, pneumatic, and/or …

USPTO Abstract

Automated drug delivery systems and related methods are disclosed herein. In some embodiments, these systems can reduce or eliminate infusion inconsistencies. An exemplary system can include a syringe actuator which can be controlled via electrical, mechanical, pneumatic, and/or hydraulic means to precisely infuse and/or withdraw material from a patient.

Drugs covered by this patent

Patent Metadata

Patent number
CA3032123A1
Jurisdiction
CA
Classification
—
Expires
2018-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Alcyone Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.